Description
Interferon epsilon (IFNe) is a unique member of the type I interferon family which is constitutively expressed by mucosal epithelia. We recently reported that IFNe can suppress metastasis of ovarian cancer through regulation of immune cells. Projects are available in our lab to investigate the mechanism of action of IFNe in cancer.
References & further reading:
https://www.nature.com/articles/s41586-023-06421-w
https://www.sciencedirect.com/science/article/abs/pii/S1044532319300636
https://academic.oup.com/jleukbio/article-abstract/111/2/337/6885170?login=false
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
cancer, immunology, interferon, immunotherapy
School
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research
Available options
PhD/Doctorate
Honours
Short projects
Time commitment
Full-time
Part-time
Top-up scholarship funding available
No
Physical location
Monash Health Translation Precinct (Monash Medical Centre)
Research webpage
Co-supervisors
Prof
Paul Hertzog